The Crossroads of Precision Medicine and Therapeutic Decision-Making: Use of an Analytical Computational Platform to Predict Response to Cancer Treatments
Metastatic cancer is a medical challenge that has been historically resistant to treatments. One area of leverage in cancer care is the development of molecularly-driven combination therapies, offering the possibility to overcome resistance. The selection of optimized treatments based on the complex...
Main Authors: | Amélie Boichard, Stephane B. Richard, Razelle Kurzrock |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/1/166 |
Similar Items
-
Precision medicine: A new paradigm in therapeutics
by: Neha Akhoon
Published: (2021-01-01) -
Promoting Precision Cancer Medicine through a Community-Driven Knowledgebase
by: Nophar Geifman, et al.
Published: (2014-12-01) -
Application of Organoids in Lung Cancer Precision Medicine
by: Ziqi JIA, et al.
Published: (2020-07-01) -
Precision cancer therapeutics for glioma
by: Danny Tat Ming Chan
Published: (2018-01-01) -
Study Progress of Radiomics in Precision Medicine for Lung Cancer
by: Zhang SHI, et al.
Published: (2019-06-01)